Abstract
To evaluate in a cohort of 100 consecutive patients affected by primary Sjogren’s syndrome (pSS) the incidence of Hashimoto thyroiditis (HT) and to compare the clinical features and the laboratory parameters of patients affected by pSS with and without concomitant HT. In 100 consecutive patients affected by pSS, the occurrence of other autoimmune diseases was recorded and a full examination of thyroid function obtained. HT was associated with pSS in 27 cases. The comparison between pSS cases with and without HT showed that only patients with isolated pSS had low C4 level [p = 0.032, OR (IC 95 %) 230 (13.13–4,046)]. In addition, only patients affected by pSS without HT had evidence of cryoglobulins, cutaneous vasculitis with palpable purpura, peripheral neuropathy, and development of lymphoma, although all these manifestations were observed in a 4.1–8.2 % of the cases, without reaching statistical significance. The association of HT in patients suffering from pSS defines a subset of patients with milder disease and normal C4 levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zeher M, Horvath IF, Szanto A, Szodoray P (2009) Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid 19:39–45
D’Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthr Care Res 49:804–809
Horvath IF, Szodoray P, Zeher M (2008) Primary Sjogren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 27:1479–1483
Ramos-Casals M, Garcia-Carrasco M, Cervera R, Gaya J, Halperin I, Ubieto I, Aymamí A, Morlà RM, Font J, Ingelmo M (2000) Thyroid disease in primary Sjogren’s syndrome. Study in a series of 160 patients. Medicine (Baltimore) 79:103–108
Orgiazzi J (1999) The spectrum of autoimmune thyroid diseases (AITD). Ann Med Interne (Paris) 150:294–300
Jara LJ, Navarro C, Brito-Zeron MP, Garcia-Carrasco M, Escarcega RO, Ramos-Casals M (2007) Thyroid disease in Sjogren’s syndrome. Clin Rheumatol 26:1601–1606
Appenzeller S, Pallone AT, Natalin RA, Costallat LT (2009) Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15:117–119
Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I (1993) Linkage studies of HLA and primary Sjogren’s syndrome in multicase families. Arthr Rheum 36:473–484
Tiemann M, Asbeck R, Wacker HH (1996) Clonal B-cell reaction in Sjogren’s disease and Hashimoto’s autoimmune thyroiditis. Pathologe 17:289–295
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558
Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthr Rheum 23:581–590
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luhtra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
Higgins JPT, Green S (eds) (2005) Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; section 8. In: The Cochrane library, issue 3. Wiley, Chichester
Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren’s syndrome. Ann Rheum Dis 64:1062–1064
Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM (2007) Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 27:407–410
Ioannidis JPA, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthr Rheum 46:741–747
Ramos-Casals M, Brito-Zeron P, Yaque J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren’s syndrome. Rheumatology 44:89–94
Avouac J, Airò P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y (2010) Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 37:608–614
Punzi L, Ostuni PA, Betterle C, De Sandre P, Botsios C, Gambari PF (1996) Thyroid gland disorders in primary Sjögren’s syndrome. Rev Rhum 63:809–814
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caramaschi, P., Biasi, D., Caimmi, C. et al. The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int 33, 1271–1275 (2013). https://doi.org/10.1007/s00296-012-2570-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2570-6